TERN
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing a portfolio of small-molecule therapeutics to address serious diseases, with an emphasis on oncology and metabolic conditions such as obesity. The company conducts its research and development activities to advance drug candidates through clinical trials with the aim of delivering targeted cancer therapies and metabolic disease treatments. While the site highlights its headquarters and leadership, it emphasizes a global outlook in oncology and metabolic programs.
No recent news for this company.